Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors

Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors

Abstract Introduction The systemic immune-inflammation index (SII) has emerged as a promising prognostic marker in various malignancies. However, its prognostic significance in patients with small-cell lung cancer (SCLC) treated with immune checkpoint inhibitors (ICIs) remains unclear. In this study...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusuke Hamakawa, Ayumi Hirahara, Akiko Hayashi, Kota Ito, Hiroyuki Shinohara, Aya Shiba, Yuko Higashi, Masaharu Aga, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Yukiko Nakamura, Tsuneo Shimokawa, Hiroaki Okamoto
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Small-cell lung cancer
Immune checkpoint inhibitor
Systemic immune-inflammation index
Neutrophil-to-lymphocyte ratio
Prognostic biomarker
Online Access:https://doi.org/10.1186/s12885-025-13440-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items